Amarin Corp Plc (AMRN)

[Biobillionair]

Let me be crystal clear, Amarin stock as a publicly traded company is dead, nothing can undo the FDA's anticompetitive actions. This includes granting NCE and "letting" Amarin market off free speach. Amarin business plan was modeled to sell company after FDA Marine approval & NCE granted.

Absolutely nothing can correct the NCE delay, Anchor rescindment, and violations of First preventing truthful marketing.

Nothing, dead.

FDA & HHS must be litigated in open court to get justice and damaged due. I'd start at $12 Billion.

Nothing on PACER

Amarin releases poster data, and gives no list of indication for Vascepa use. Guessing letter allows Amarin to market truthful info. I wouldn't drop the suit and I would attach the anticompetitive complaint.

FDA intensional killed this company.

BB